You are here

  • Home
  • Archive
  • Volume 47, Issue 3
  • 10% lidocaine spray for pain control during intrauterine device insertion: a randomised, double-blind, placebo-controlled trial

Article info

Article menu

Download PDFPDF

Original research
10% lidocaine spray for pain control during intrauterine device insertion: a randomised, double-blind, placebo-controlled trial
Free

Authors

  • Nalinee Panichyawat Family Planning and Reproductive Health Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • Theethat Mongkornthong Family Planning and Reproductive Health Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • Thanyarat Wongwananuruk Family Planning and Reproductive Health Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • Korakot Sirimai Family Planning and Reproductive Health Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nalinee Panichyawat, Obstetrics and Gynecology, Mahidol University Faculty of Medicine Siriraj Hospital, Bangkok 10700, Thailand; nalinee.pan{at}mahidol.ac.th
View Full Text

Citation

Panichyawat N, Mongkornthong T, Wongwananuruk T, et al
10% lidocaine spray for pain control during intrauterine device insertion: a randomised, double-blind, placebo-controlled trial
BMJ Sexual & Reproductive Health 2021;47:159-165.

Publication history

  • Received April 21, 2020
  • Revised May 27, 2020
  • Accepted June 2, 2020
  • First published June 26, 2020.
Online issue publication 
January 10, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.